Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 4/20 | 0.55 |
| ▸ | APP | P05067 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PTPRA | P18433 | 1/20 | 0.48 |
| ▸ | PTPRB | P23467 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93700 | 1.00 | APP (0.72) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL93701 | 1.00 | APP (0.72) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL29912825 | 0.98 | APP (0.69) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL5159519 | 0.90 | MAPK1 (0.74) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL14471820 | 0.90 | MAPK1 (0.74) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL1638375 | 0.90 | MAPK1 (0.73) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL10621059 | 0.90 | MAPK1 (0.73) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL29421649 | 0.90 | MAPK1 (0.73) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL29408777 | 0.87 | THRB (0.58) | APPALDH1A1MAPK1THRBTDP1 | |
| SCHEMBL29366329 | 0.86 | THRB (0.65) | APPALDH1A1MAPK1THRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1728 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716527-A1 | A MULTIPLE UNIT ORAL DOSAGE FORM OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE FREE OF TITANIUM DIOXIDE | Italfarmaco SpA (IT) | 2026-04-01 | — | — | EP | claimed |
| WO-2025229356-A1 | ORAL HYDRATION SOLUTION | AQABELA LTD (GB) | 2025-11-06 | — | — | WO | claimed |
| EP-4605242-A1 | AN AQUEOUS BIOINK SOLUTION FOR USE IN LIGHT-BASED BIOPRINTING APPLICATIONS, AND METHODS OF USING THE AQUEOUS BIOINK SOLUTION | CELLINK Bioprinting AB (SE) | 2025-08-27 | — | — | EP | claimed |
| EP-3958926-B1 | MULTIVASCULAR NETWORKS AND FUNCTIONAL INTRAVASCULAR TOPOLOGIES WITHIN BIOCOMPATIBLE HYDROGELS | UNIV RICE WILLIAM M (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3778795-B1 | INKJET INK AND TABLET | TOPPAN PRINTING CO LTD (JP) | 2025-08-13 | — | — | EP | claimed |
| US-20250228644-A1 | METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE | EPHEMERAL SOLUTIONS, INC. | 2025-07-17 | — | — | US | claimed |
| US-20250194586-A1 | DISINFECTANT COMPOSITION | WHITELEY CORP PTY LTD (AU) | 2025-06-19 | — | — | US | claimed |
| US-20250186407-A1 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING A MACROLIDE IMMUNOSUPPRESSANT | NUCLEUS MEDICAL GMBH (DE) | 2025-06-12 | — | — | US | claimed |
| CN-120091914-A | Aqueous bio-ink solution for light-based bio-printing applications and method of using the same | 塞尔林克生物打印有限责任公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025097045-A1 | COLLOIDAL FOOD BASE COMPOSITIONS COMPRISING MYCELIAL BIOMASS | THE FYNDER GROUP, INC (US) | 2025-05-08 | — | — | WO | claimed |
| US-20220202750-A1 | DYE COMPOSITION FOR MARKING ORGANIC TISSUE WITH ANAESTHETIC AND METHOD FOR APPLYING SAME | HEXSEL, DORIS MARIA (BR) | 2022-06-30 | — | — | US | claimed |
| CN-114456958-A | Salt-tolerant pichia guilliermondii strain with azo dye degradation function, culture method and application thereof | 辽宁师范大学 | 2022-05-10 | — | — | CN | claimed |
| US-20220125922-A1 | Photosensitive Dyes and Method of Using Said Dyes | STRT LLC (US) | 2022-04-28 | — | — | US | claimed |
| CN-114388077-A | Traditional Chinese medicine dyed material database based on micro-focusing Raman technology and application thereof in identification of traditional Chinese medicine dyed materials | 成都市食品药品检验研究院 | 2022-04-22 | — | — | CN | claimed |
| US-20220111050-A1 | BIOPHOTONIC COMPOSITIONS, METHODS, AND KITS FOR INHIBITING AND DISRUPTING BIOFILMS | FLE INTERNATIONAL S.R.L. (IT) | 2022-04-14 | — | — | US | claimed |
| WO-2022072467-A1 | COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE | DECIMADX, LLC (US) | 2022-04-07 | — | — | WO | claimed |
| CN-114245751-A | Multi-channel networks and functional in-channel topologies within biocompatible hydrogels | 威廉马歇莱思大学 | 2022-03-25 | — | — | CN | claimed |
| CN-114213900-A | Watercolor ink capable of halation dyeing and multiple color folding and paper breaking and preparation method thereof | 广东肇庆市红鹰科技有限公司 | 2022-03-22 | — | — | CN | claimed |
| WO-2022043560-A1 | PEELABLE WRITING INK COMPOSITION WITH COLOR-CHANGING FOR WRITING POROUS SUBSTRATES | SOCIETE BIC (FR) | 2022-03-03 | — | — | WO | claimed |
| EP-3958926-A1 | MULTIVASCULAR NETWORKS AND FUNCTIONAL INTRAVASCULAR TOPOLOGIES WITHIN BIOCOMPATIBLE HYDROGELS | William Marsh Rice University (US) | 2022-03-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186407-A1 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING A MACROLIDE IMMUNOSUPPRESSANT | TMSB4X, TMSB10, PIGS | THRB 3634/4885APP 4632/4885ALDH1A1 3645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.